Surescripts Leads Industry-Wide NCPDP Upgrades to Improve Patient Safety, Workflow Efficiency

Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Jun 18, 2024 12:00 pm

Surescripts®, the nation’s leading health information network, is working to implement the National Council for Prescription Drug Programs (NCPDP) SCRIPT Standard Version 2023011, Real-Time Prescription Benefit v13 and Formulary and Benefit v60 standards upgrades following the Center for Medicare and Medicaid Services (CMS) publication of the final rule on June 13, 2024.

“These standards upgrades make critical improvements to a number of essential exchanges of patient clinical and benefit information that support better quality care and ensure the highest level of patient safety possible,” said Tara Dragert, Chief Product Officer for Surescripts. “We will continue to work closely with NCPDP and Surescripts Network Alliance participants to seamlessly implement these upgrades, focusing on the needs of patients and those who care for them.”

Surescripts is upgrading several solutions to meet the NCPDP SCRIPT Standard Version 2023011, including E-Prescribing, Electronic Prior Authorization and Medication History for Ambulatory & Medication History for Reconciliation, in addition to the Real-Time Prescription Benefit v13 and Formulary and Benefit v60 standards which apply to Surescripts Real-time Prescription Benefit and Formulary that help prescribers make better informed and less costly prescription medication decisions alongside patients.

“We are pleased that the final rule has been announced for the updated versions of the named NCPDP SCRIPT and Formulary & Benefit Standards and the newly named NCPDP Real-Time Prescription Benefit Standard,” said Lee Ann Stember, President & CEO of NCPDP. “These standards provide for the seamless exchange of data for better informed clinical decision making at the point of care to improve healthcare quality and patient safety. We look forward to supporting effective implementation of these important standards with education and tools as industry stakeholders begin planning for these updates.”

CMS has established the following compliance dates for entities to transition to the new standards:

  • January 1, 2027 – Real Time Prescription Benefit v13 and Formulary and Benefit v60; and
  • January 1, 2028 – SCRIPT Standard Version 2023011.

“We’ve spent the last few months preparing for these standards upgrades with the Network Alliance, offering education sessions, along with ongoing communications and self-service tools to make this upgrade process as simple as possible as we continue to improve health intelligence sharing across the country,” Dragert added.

The NCPDP SCRIPT Standard Version 2023011 will replace the NCPDP SCRIPT Standard Version 2017071 as the Part D Electronic Prescribing Standard.

The National Council for Prescription Drug Programs (NCPDP) is a not-for-profit American National Standards Institute (ANSI) accredited Standards Developer (ASD) consisting of more than 1,500 members representing entities including, but not limited to, claims processors, data management and analysis vendors, federal and state government agencies, insurers, intermediaries, pharmaceutical manufacturers, pharmacies, pharmacy benefit managers, professional services organizations, software and system vendors and other parties interested in electronic standardization within the pharmacy services sector of the healthcare industry.

More information about the upgrades:


For the last two decades, Surescripts has served the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care is accessible to patients no matter where they live.

In 2023, Surescripts and the network alliance, have continued to evolve as the nation’s leading health information network, supporting nearly 24 billion exchanges of patient clinical and benefit information, connecting 2.14 million care providers and organizations and reaching more than 99% of the U.S. population.

Surescripts is committed to advancing health intelligence sharing and focuses on innovations that aim to help healthcare heal itself, delivering real-time care and cost intelligence that dramatically improves the lives of patients and those who care for them.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we align healthcare organizations across the nation and convene the Surescripts Network Alliance® to give healthcare professionals the trusted insights they need to serve patients. Together, we’re making interoperability an everyday reality, making it simpler to choose medications patients can afford and adhere to, and getting specialty medications to patients more efficiently. Visit us at and follow us on LinkedIn.

Kate Giaquinto
(571) 290-6859
[email protected]

Comment On!

Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to (via Easy Blurb).